Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Brasil Bio Fuels S A is currently prosecuting patent applications within the Biotechnology & Pharmaceuticals technology area. The data shows 2 pending office actions, which indicates a focused effort to secure intellectual property in this specialized field. These actions are being handled by 1 distinct examiner, providing a single point of contact for the company's current pending matters.
The prosecution is further concentrated within 1 distinct art unit. This total focus suggests that the company's innovations are situated within a narrow technical or regulatory category. For a practitioner, this means that the prosecution strategy must be closely aligned with the specific standards and historical tendencies of this art unit to ensure successful outcomes.
CUTLIFF, YATE KAI RENE is identified as the busiest examiner for this portfolio, overseeing 2 pending office actions. Since this examiner is responsible for all the current activity, their individual examination style and preferences will be the primary influence on the company's prosecution results. This centralized workload allows for a consistent approach but also means that the portfolio's progress is entirely dependent on the decisions made by this examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CUTLIFF, YATE KAI RENE | 2 | 79.8% | +24.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18596105 | PLASTIFICANTE NATURAL DERIVADO DE ESTERES GRAXOS COM ALTO CONTEUDO DE EPOXI | CUTLIFF, YATE KAI RENE | — |
| 18596126 | Unknown | CUTLIFF, YATE KAI RENE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18596105 | PLASTIFICANTE NATURAL DERIVADO DE ESTERES GRAXOS COM ALTO CONTEUDO DE EPOXI | CUTLIFF, YATE KAI RENE | — |
| 18596126 | Unknown | CUTLIFF, YATE KAI RENE | — |
| Art Unit | Apps |
|---|---|
| 1692 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18596105 | PLASTIFICANTE NATURAL DERIVADO DE ESTERES GRAXOS COM ALTO CONTEUDO DE EPOXI | CUTLIFF, YATE KAI RENE | 1692 | §101§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18596126 | Unknown | CUTLIFF, YATE KAI RENE | 1692 | §102§103§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBrasil Bio Fuels S A has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Yate Kai Rene Cutliff has the most, with 2 of Brasil Bio Fuels S A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
